Biotricity (OTCMKTS:BTCY – Get Free Report) and MSP Recovery (NASDAQ:MSPR – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, analyst recommendations, risk, institutional ownership, profitability and earnings.
Profitability
This table compares Biotricity and MSP Recovery’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Biotricity | -37.33% | N/A | -94.07% |
| MSP Recovery | -4,375.62% | -326.80% | -61.32% |
Institutional and Insider Ownership
3.9% of Biotricity shares are held by institutional investors. Comparatively, 3.8% of MSP Recovery shares are held by institutional investors. 10.1% of Biotricity shares are held by insiders. Comparatively, 50.5% of MSP Recovery shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Biotricity | $12.06 million | 1.16 | -$8.42 million | ($0.21) | -2.49 |
| MSP Recovery | $13.28 million | 0.09 | -$360.50 million | ($522.40) | 0.00 |
Biotricity has higher earnings, but lower revenue than MSP Recovery. Biotricity is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Biotricity has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, MSP Recovery has a beta of -2.53, meaning that its stock price is 353% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings for Biotricity and MSP Recovery, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Biotricity | 0 | 0 | 0 | 0 | 0.00 |
| MSP Recovery | 1 | 0 | 0 | 0 | 1.00 |
Summary
Biotricity beats MSP Recovery on 7 of the 12 factors compared between the two stocks.
About Biotricity
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
About MSP Recovery
MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.
Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.
